To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections, impressions, and insights on the biotechnology industry and the life sciences. We also queried them on what they believe the future might look like for biotechnology. We sought the thoughts […]

Current standard-of-care procedures used to treat complex and chronic wounds are often highly invasive, with low efficiencies and high complication rates. To address the significant unmet medical needs in chronic wound treatment, PolarityTE is developing a range of regenerative tissue products utilizing a patient’s own cells and tissues, such as SkinTE®. Technology Networks recently spoke […]

Cancer death rates in the United States have been steadily declining despite a concurrent steady rise in cancer diagnoses.1 This is partly driven by innovations in cancer treatment that are providing many patients with prolonged survival. These innovations, however, have introduced new challenges for physicians in managing the toxicities of chronic cancer treatment. One significant toxicity […]